EMEA-000410-PIP01-08-M04
Key facts
Invented name |
Rapiscan
|
Active substance |
regadenoson
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0030/2019
|
PIP number |
EMEA-000410-PIP01-08-M04
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Diagnosis of myocardial perfusion disturbances
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
GE Healthcare AS
Tel. +44 1494 543259 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|